Association for accessible medicines

Replay of the Generic Medicines Day webinar (in Dutch and French)

Biosimilar medicines

Biosimilar medicines contain the same active substance and have the same therapeutic effect as branded medicines. Their price is at least 35,8% to minimum 43,54% lower than the original price of the branded medicine. Biosimilars are essential to making expensive biologic treatments available as widely as possible.

Generic medicines

Generic medicines contain the same active substance and have the same therapeutic effect as branded medicines. Their price is at least between 54% and 65% lower than the original price of the branded medicine. Generic medicines allow more patients to be better treated.

Self-care products

Self-care products are products that are freely available at pharmacies, such as self-care medicines, self-care medical devices and food supplements. Patients can use them upon their own initiative, to preserve their health. Their ‘good use’ substantially reduces the social costs of being ill.

News

With the support of the Belgian and Luxembourg Competent Authorities, in 2018 the pharmaceutical industry launched the 'e-PIL' pilot project in Belgian and Luxembourg hospitals. The project is the result of a derogation obtained from the European Commission. In this pilot project, a selection of medicines on the Belgian and Luxembourg market are not accompanied by their patient paper inserted leaflet (PIL). 

 

 

For the treatment of the Corona virus, Medaxes refers to the scientific guidelines issued by the scientific institutions of our country.

These informations are regularly updated, taking into account the latest scientific findings. For more information, please click on Sciensano Epidemio

            Video about Medaxes

/sites/default/files/styles/banner/public/2018-10/caleb-jones-135058.jpg?h=28fdc21a&itok=wU_tyZE5

Our members